Bradley McGregor

30PUBLICATIONS
277CO-AUTHORS
Predictive and prognostic markersMolecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Nov 07, 2026
Functional epigenomic liquid biopsy identifies potential therapeutic vulnerabilities after enfortumab vedotin-pembrolizumab resistance in metastatic urothelial carcinoma (mUC).

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Jul 01, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

|Jan 26, 2026
ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer.

Ilana B Epstein, Adetolani Odogiyon, Stephanie Berg

Pageof 5

Frequent Collaborators

13 joint publications

Toni K Choueiri

9 joint publications

Rana R McKay

5 joint publications

Stephanie Berg

5 joint publications

Wanling Xie